医学
急性肾损伤
肾功能
肌酐
碘普罗胺
内科学
造影剂肾病
胱抑素C
不利影响
心脏病学
泌尿科
入射(几何)
灌注
经皮冠状动脉介入治疗
心肌梗塞
造影剂
放射科
物理
光学
作者
Xiaocong Zhang,Chun Yao,Xiao Qunlin,Jiansheng Wu,Guifu Wu
标识
DOI:10.1016/j.cct.2021.106653
摘要
Contrast-induced acute kidney injury (CI-AKI) is a common complication after exposure to contrast media. Renal ischaemia occurs in the initial stage of CI-AKI, however, there are very few effective measures to improve renal perfusion.A total of 114 patients with an estimated glomerular filtration rate (eGFR) of 60-89 ml/min/1.73m2 were randomly assigned to two groups: enhanced external counterpulsation (EECP) group (N = 57) and control group (N = 57). Two hours after contrast exposure, EECP group received EECP treatment for 1 h while no intervention was performed control group. The primary outcome was the incidence of serum cystatin C concentration to 10% above the baseline concentration at 24 h after contrast administration. The secondary outcomes were the incidence of CI-AKI (defined as an increase in serum creatinine concentration to ≥0.5 mg/dl or by 25% compare to the baseline after contrast exposure), contrast clearance and adverse clinical events.The primary outcome was observed in 26 patients (6 EECP and 20 control; 11% vs. 35%; P = 0.002). CI-AKI occurred in four patients (0 EECP and 4 control; 0% vs. 7%; P = 0.042). The clearance rate of iopromide in the initial 3 h was significantly different between EECP and control group (59.92 ± 8.84 vs 46.80 ± 9.26 ml/min/1.73 m2; P < 0.001). No adverse clinical events were observed in this study.This study demonstrates that EECP increases the contrast clearance and may have an effect in reducing the risk of CI-AKI. The study has been registered in Chinese Clinical Trial Registry (ChiCTR 2,000,039,190).
科研通智能强力驱动
Strongly Powered by AbleSci AI